Skip to main content

Table 1 Included studies of HBV, HCV and HBV/HCV co-infections in prisoners with HIV

From: The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis

Row Author year Country WHO regions Design Mean age Number of prisoners living with HIV Number of people with HBV co-infection HBV co-infection prevalence (95% CI)* Number of people with HCV co-infection HCV co-infection prevalence
(95% CI)*
Quality of study
1 Smith et al. [66] 1991 USA America Cross-sectional 29.4 90 3 3.3 (1.0 -9.2) - - High
2 Vlahov et al. [31]
1993
USA America Cross-sectional - 23 - - 20 86.9 (68.1–95.0) Medium
3 Bulter et al. [19] 1997 Australia Western Pacific Cross-sectional 30.6 (10.1) 408 125 30.6 (26.3 -35.1) 150 36.7 (32.0–42.4) High
4 Pallas et al. [2, 21] 1999 Spain Europe Cross-sectional 27.2 (5.4) 156 5 3.2 (1.0–7.1) 9 5.7 (3.2–10.9) Medium
5 Massed et al. [20] 1999 Brazil America Cross-sectional 30.8 211 - - 75 35.5 (29.3–41.8) Medium
6 Guimarães et al. [22]
2001
USA America Cross-sectional 30.2 105 - - 54 51.4 (423–61.4) High
7 Quaglio et al. [24] 2003 Italy Europe Cross-sectional 30 (7) 133 - - 128 96.2 (91.9–98.0) Medium
8 Baillargeon et al. [23]
2003
USA America Cross-sectional - 46 - - 24 52.1 (38.0–65.7) Medium
9 Solomon et al. [26] 2004 USA America Cross-sectional - 220 - - 144 65.4 (59.2–71.1) Low
10 Rui Passadouro et al. [25]
2004
Portugal Europe Cross-sectional 32.3 47 38 87.2 (75.0–94.3) 41 80.8 (67.2–90.0) Low
11 Hoya et al. [27]
2005
Spain Europe Cross-sectional 34.2 (6.2) 146 - - 137 93.8 (88.8–97.2) Low
12 Babudieri et al. [65] 2005 Italy Europe Cross-sectional 36 73 54 74.0 (63.1–83.4) 59 81.2 (70.1–88.0) Medium
13 Khodabakhsi et al. [28]
2007
Iran Eastern Mediterranean Cross-sectional - 7 1 14.2 (3.0–51.3) 3 42.8 (16.1–75.0) High
14 Calzavara et al. [29]
2007
Canada America Cross-sectional - 25 - - 17 68.0 (48.1–83.4) Medium
15 Poulin et al. [30]
2007
Canada America Cross-sectional - 54 - - 35 64.8 (51.3–76.1) Medium
16 Baillargeon et al. [32]
2008
USA America Prospective cohort - 6168 312 5.0 (4.9–6.3) 2275 36.8 (36.0–38.1) Low
17 Barros et al. [33]
2008
Portugal Europe Cross-sectional - 41 - - 20 48.7 (34.0–59.7) High
18 Pontali et al. [1, 34]
2008
Italy Europe Prospective cohort - 164 11 6.7 (4.3–12.1) 149 90.0 (85.3–94.2) Low
19 Davoodian et al. [36]
2009
Iran Eastern Mediterranean Cross-sectional 35.4 (8.4) 38 3 7.8 (3.0–20.8) 36 94.7 (83.2–99.0) Low
20 Hennessey et al. [37]
2009
USA America Cross-sectional - 168 14 8.3 (5.2–14.0) 64 38.0 (31.1–46.2) High
21 Rosen et al. [38]
2009
USA America Cross-sectional - 718 - - 487 67.8 (63.8 -71.0) Medium
22 Adoga et al. [64]
2009
Nigeria Africa Cross-sectional 29.2 54 8 14.8 (8.0–27.2) - - Medium
23 Chu et al. [35]
2009
Taiwan Western Pacific Cross-sectional 31.4 (7.2) 52 6 11.5 (5.0–23.3) 51 98.0 (90.1–99.9) Medium
24 Sánchez et al. [39]
2009
Taiwan Europe Cross-sectional - 188 - - 167 88.8 (83.7–93.7) High
25 Nelwan et al. [41]
2010
Indonesia South East Asia Cross-sectional 28.9 63 2 3.1 (1.0–11.2) 52 82.5 (71.3–90.4) Medium
26 Hosseini et al. [40]
2010
Iran Eastern Mediterranean Cross-sectional - 102 - - 100 98.0 (93.0–99.4) Medium
27 Mir-Nasseri et al. [43]
2011
Iran Eastern Mediterranean Cross-sectional 35.85 63 3 4.7 (2.0–12.9) 56 88.8 (79.3–95.0) High
28 Nafees et al. [44]
2011
Pakistan Eastern Mediterranean Cross-sectional - 99 1 1.0 (0.1–6.2) 73 74.7 (64.2–81.0) High
29 Da Siva et al. [42]
2011
Portugal Europe Cross-sectional 34.1 (10.8) 10 - - 8 80.0 (49.1–94.1) Low
30 Marco et al. [45]
2012
Spain Europe Cross-sectional 35.7 (10.3) 40 2 5.0 (1.0–17.2) 34 85.0 (71.0–93.0) Medium
31 Prasetyo et al. [48]
2013
Indonesia South East Asia Cross-sectional 32.3 18 - - 15 83.3 (61.0–93.8) Low
32 Semaille et al. [49]
2013
France Europe Cross-sectional 34 (0.56) 26 - - 2 7.6 (2.3–24.1) Medium
33 Mourino et al. [46]
2013
Spain Europe Cross-sectional 34.4 (7.4) 47 3 6.3 (1.9–17.0) 30 63.8 (50.0–76.4) High
34 Brandolini et al. [47]
2013
Italy Europe Cross-sectional 43.2 (11.18) 67 - - 60 89.5 (80.2–95.0) High
35 Azbel et al. [9]
2013
Ukraine Europe Cross-sectional 31.9 78 - - 72 92.3 (84.0–96.5) High
36 Alvareza et al. [6]
2014
USA America Cross-sectional 37.4 (10.9) 119 - - 47 39.4 (31.0–48.0) Medium
37 Marco et al.[10]
2014
Spain Europe Prospective cohort 39.7 (11) 46 - - 19 41.3 (28.5–56.0) High
38 Rodriguez et al. [50]
2014
USA America Cross-sectional 39 37 - - 31 83.7 (69.4–92.3) Medium
39 Escudero et al. [51]
2014
Afghanistan Eastern Mediterranean Cross-sectional - 39 - - 37 94.8 (82.7–99.0) Low
40 Chan et al. [52] 2015 United Kingdom Europe Cross-sectional - 151 5 3.3 (1.0–8.0) 33 21.8 (16.5–29.2) Low
41 Farhoudi et al. [54]
2016
Iran Eastern Mediterranean Cross-sectional - 85 3 3.5 (1.5–10.2) 50 58.8 (48.0–69.2) High
42 Sanarico et al. [56]
2016
Italy Europe Cross-sectional - 69 8 11.5.00 (5.6–21.1) 8 11.5 (6.0–20.9) Medium
43 Pontali et al. [2, 56]
2016
Italy Europe Cross-sectional - 365 25 6.8 (5.1–10.3) 291 89.7 (74.9–84.3) High
44 Gabriel et al. [53]
2016
Malaysia Western Pacific Cross-sectional 35.2 (10.1) 221 - - 200 90.4 (86.0–94.2) High
45 Pontali et al. [3, 58]
2017
Italy Europe Cross-sectional 45.7 85 2 2.3 (1.3–8.5) 46 54.1 (44.1–64.0) High
46 Puga et al. [61]
2017
Brazil America Cross-sectional 32 (10) 54 - - 5 9.2 (4.0–20.4) Medium
47 Retana et al. [62]
2017
USA America Cross-sectional 33.28 18 - - 2 11.1 (3.4–33.1) Medium
48 Flor et al. [59]
2017
USA America Cross-sectional - 30 - - 6 20.0 (10.0–37.0) Medium
49 Baillargeon et al. [7]
2017
USA America Cross-sectional 37 (11.3) 2960 - - 708 23.9 (21.7–25.5) Medium
50 Akiyama et al. [57]
2017
USA America Cross-sectional - 1197 - - 331 27.6 (24.8–30.3) Medium
51 Prestileo et al. [60]
2017
Italy Europe Prospective cohort 35.5 30 4 13.3 (5.0–30.2) 16 53.3 (36.5–70.1) Medium
52 Kivimets et al. [63]
2018
Estonia Europe Cross-sectional 34.1 (10.92) 469 - - 379 81.8 (77.0–84.3) Medium
  1. *Prevalence was provided per 100 people